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Abstract
Ghrelin is a stomach-derived peptide that has been identified as the only circulating hunger hormone that exerts a potent
orexigenic effect via activation of its receptor, the growth hormone secretagogue receptor (GHS-R1a). Hence, the
ghrelinergic system represents a promising target to treat obesity and obesity-related diseases. In this study we analysed
the GHS-R1a receptor activating potential of Harpagophytum procumbens, popularly known as Devil’s Claw, and its effect on
food intake in vivo. H. procumbens is an important traditional medicinal plant from Southern Africa with potent anti-
inflammatory and analgesic effects. This plant has been also used as an appetite modulator but most evidences are
anecdotal and to our knowledge, no clear scientific studies relating to appetite modulation have been done to this date.
The ghrelin receptor activation potential of an extract derived from the dried tuberous roots of H. procumbens was analysed
by calcium mobilization and receptor internalization assays in human embryonic kidney cells (Hek) stably expressing the
GHS-R1a receptor. Food intake was investigated in male C57BL/6 mice following intraperitoneal administration of H.
procumbens root extract in ad libitum and food restricted conditions. Exposure to H. procumbens extract demonstrated a
significant increased cellular calcium influx but did not induce subsequent GHS-R1a receptor internalization, which is a
characteristic for full receptor activation. A significant anorexigenic effect was observed in male C57BL/6 mice following
peripheral administration of H. procumbens extract. We conclude that H. procumbens root extract is a potential novel source
for potent anti-obesity bioactives. These results reinforce the promising potential of natural bioactives to be developed into
functional foods with weight-loss and weight maintenance benefits.
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Introduction
Ghrelin is a 28 amino acid peptide, which is synthetized mainly
in the stomach, identified as the first and only known peripheral
hormone exerting an appetite-stimulating effect through activation
of its receptor, the growth hormone secretagogue receptor (GHS-
R1a) [1]. Indeed, several studies have shown the orexigenic effects
of ghrelin following central or peripheral administration [2–4].
Although this receptor is also implicated in the central secretion of
the growth hormone (GH) from the anterior pituitary cells [5], its
role in the appetite modulation is via activation of orexigenic
neurons in the hypothalamic arcuate nucleus (ARC) (for review see
[6].
A dysregulated appetite signalling, including aberrant ghrelin
signalling, may contribute to the development of metabolic
disorders such as obesity [7]. The World Health Organization
(WHO) defines obesity and overweight as ‘‘abnormal or excessive
fat accumulation that may impair health’’ [8]. The prevalence of
obesity has been continuously increasing since 1980 and is
reaching epidemic proportions in both developed and developing
countries. Recent numbers show that more than 1.6 billion adults
are overweight (BMI $25 kg/m2) and 400 million of them are
clinically obese (BMI $30 kg/m2) [8]. In addition, obesity and
being overweight are the fifth leading risk for mortality. The high
rate of obesity has led to increases in complications associated with
obesity, notably the Metabolic Syndrome (Reaven’s Syndrome X;
the Insulin Resistance Syndrome) which includes cardiovascular
risk factors such as insulin resistance (type 2 diabetes), glucose
intolerance, dyslipidemia and hypertension [8].
Moreover, current available anti-obesity therapeutics are
limited and associated with adverse side effects, emphasising the
urgent need for novel strategies contributing to the maintenance of
a healthy weight [9,10]. The ghrelinergic system represents a
promising pharmacologic target for the treatment of obesity and
obesity-related diseases. Indeed, several studies have shown that
inhibition of the ghrelin signalling pathway results in a reduction
of food intake through decreased appetite and increased energy
expenditure and fat catabolism, underlining the potential of
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ghrelin receptor antagonists, inverse agonist and other strategies
targeting the ghrelin hormone in the development of anti-obesity
therapeutics (for review see[7,11–15]).
Over the past decade, scientific research has demonstrated anti-
obesity effects in bioactives from plants (for review see [16,17]).
Appetite modulating bioactives from natural resources may be an
interesting alternative for current anti-obesity drugs contributing
to an enhanced safety profile to treat metabolic disorders [18]. In
this study, we investigate the effect of a plant extract derived from
the dried tuberous roots of Harpagophytum procumbens on GHS-
R1a receptor modulation in vitro and on food intake in vivo. This
plant, commonly known as Devil’s Claw, is a perennial herb from
the Kalahari region of Southern Africa, where it has historically
been used in traditional medicine with anti-inflammatory,
analgesic, anti-oxidant, anti-diabetic, antimicrobial, anti-malarial,
anticancer, hypotensive and cardiodepressant, anticonvulsant and
uterotonic activities as well as an appetite modulator (for review
see [19–21]). Therefore, this plant is becoming of interest and
several animal, clinical and in vitro studies have investigated some
of these properties, specially its anti-inflammatory and analgesic
effects (for review see [21,22]). Hence, effective treatments of
inflammation, rheumatoid arthritis, tendonitis, osteoarthritis and
dyspepsia have been shown (for review see [20]). However,
scientific studies are lacking regarding the H. procumbens appetite
modulation effect.
This study aims to investigate the ability of H. procumbens to
control appetite via modulation of the GHS-R1a receptor. To this
end, GHS-R1a receptor-mediated calcium influx is analysed using
an in vitro calcium mobilization assay. Moreover, H. procumbens
mediated anorexigenic effects are investigated in vivo.
Materials and Methods
Ethics Statement
All animal experiments were conducted in accordance with the
European Directive 86/609/EEC, the Recommendation 2007/
526/65/EC and approved by the Animal Experimentation Ethics
Committee of University College Cork (Animal ethical permit
number #2010/028). All efforts were made to minimise animal
suffering and to reduce the number of animals used.
Compositional analysis of Harpagophytum procumbens
The source of the material was a certified sample powder of
unprocessed dried Harpagophytum procumbens root obtained
from Proline Botanicals, Hull, UK (now trading as Herbs in a
Bottle, Lincolnshire, UK). The dried H. procumbens root powder
is green/brown in colour, not-irradiated and not derived from
genetically modified material, as certified by the supplier.
In addition, the chemical composition of the dried H.
procumbens root powder was analysed following different an-
alytical methods. Ash and moisture were determined using
association of analytical communities (AOAC) international
methods 942.05, and 934.01 approved methods [23], respectively.
Lipids were analysed according to the reference method 659:2009
from the International Organization for Standardization (ISO)
[24]. Saccharides were determined according to Dubois et al.,
[25]. Total fibre content was determined according to Lee, Prosky
and Devries [26]. Protein content was determined by amino acid
analysis according to Hidalgo, Alaiz and Zamora [27]. Polyphenol
content was determined using the Folin-Ciocalteou reagent as
described by Singleton, Orthofer and Lamuela-Raventos [28]
using a standard curve of catechin. Specific details on these
methods are given in Text S1. The rest of the components (62.4%)
were calculated by difference and might correspond to carbohy-
drates other than saccharides, such as insoluble carbohydrates
[29].
Cell culture
Human embryonic kidney cells (Hek293a) (Invitrogen, Dun
Laoghaire, Ireland) were maintained in culture in high glucose
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) con-
taining 10% heat inactivated fetal bovine serum (FBS) (Sigma-
Aldrich, Wicklow, Ireland) and 1% non-essential amino acids
(NEAA) (Gibco, Life Technologies, Dublin, Ireland) at culture
conditions (37uC and 5% CO2 in a humidified atmosphere).
Hek293a cells were transfected with a plasmid construct express-
ing the human GHS-R1a receptor as previously described [30]
and cultured in complete DMEM media, containing 300 ng/ml
G418 (Calbiochem, Merck KGaA, Darmstadt, Germany) as
maintenance antibiotic. Cells were grown to a confluence of .
85% and subsequently split to a lower density for continued
culturing.
Resazurin assay
Cytotoxicity of H. procumbens was determined using the
resazurin assay (R&D systems, Inc.) according manufacturer’s
instructions. Resazurin is a blue non-toxic, water soluble, redox-
sensitive dye that undergoes a colour change following reduction
by viable cells. Absorbance of the colour change is measured at
570 nm. Hek293a cells were seeded in a 96-well microtiter plate at
2.8*105 cells/ml (2.8*104 cells/well) and maintained for 48 h at
culture conditions. For the last 24 h of this time period, media was
replaced with serum free DMEM media containing 1% NEAA.
The dried H. procumbens root powder was dissolved in saline at
50 mg/mL containing 2.5% DMSO (Sigma-Aldrich). Then, it was
centrifuged for 5 min at 2000 rpm and the supernatant was used
to analyze its cytotoxicity. Cells were exposed for 4 h to this H.
procumbens root extract at different concentrations up to 10 mg/
mL, all comprising 10% resazurin dye. Cell viability was
calculated as percentage of control (cells in 1x Hanks balanced
salt solution, HBSS) (Gibco), supplemented with 20 mM HEPES
(Sigma-Aldrich). Values above 90% are not considered cytotoxic.
Calcium mobilization assay
G-protein coupled receptor-mediated changes in intracellular
calcium (Ca2+) were determined using a Flex station II multiplate
fluorometer (Molecular Devices Corporation, Sunnyvale, CA,
USA). Calcium mobilization assays were performed based on
protocols described in previous studies [31,32]. Briefly, stably
transfected Hek293a cells were seeded in black 96-well microtiter
plates at a density of 2.8*105 cells/ml (2.8*104 cells/well) and
maintained for ,24 h at culture conditions. Next, growth media
was replaced by serum free DMEM media containing 1% NEAA
and the cells were incubated for a further ,24 h at culture
conditions. After removal of the serum free DMEM media, cells
were incubated for 90 min with 25 ml of assay buffer (1x Hanks
balanced salt solution, HBSS, containing 20 mM HEPES) and
25 ml of 1x Ca4 dye (Molecular Devices Corporation, Sunnyvale,
CA, USA), according to the manufacturer’s instructions. The
dried H. procumbens root powder was dissolved in assay buffer at
100 mg/mL containing 10% DMSO. Then, the solution was
centrifuged for 5 minutes at 2000 rpm and the supernatant was
used for the assay. While we determined that 2.5% DMSO is not
toxic to cells (Figure 1), the DMSO concentration exposed
directly on the cells was no higher than 0.33% in this assay.
Fluorescent readings were taken for a total of 80 seconds at 37uC
in flex mode with excitation wavelength of 485 nm and emission
wavelength of 525 nm. Addition of ghrelin or a serial dilution of
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the test compound, H. procumbens root extract, (25 ml/well) was
performed by the Flexstation II after 16 secs during continuous
fluorescent measurements for a total of 80 secs. The relative
increase in intracellular calcium [Ca2+] was calculated as the
difference between maximum and baseline fluorescence (Vmax-
Vmin) and depicted as percentage relative fluorescent units (RFU)
normalized to maximum response (100% signal) obtained with
3.3% FBS. Background fluorescence was obtained by cells in assay
buffer alone and subtracted from RFUs. Exposure to the
endogenous agonist ghrelin (Tocris, R&D Systems, Abingdon,
UK), inverse agonist peptide [D-Arg1, D-Phe5, D-Trp7,9,
Leu11]-substance P (SP) (Tocris, R&D Systems) and harpagoside
(Santa Cruz Biotechnology, Inc.) were also carried out. Ghrelin
and [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P were
prepared in assay buffer. Exposure to H. procumbens extract
following pretreatment to the inverse agonist [D-Arg1, D-Phe5, D-
Trp7,9, Leu11]-substance P was also carried out. This pretreat-
ment was performed during the calcium dye incubation. Harpago-
side, which is the main iridoid glycoside in H. procumbens, was
solubilised in methanol and further diluted in assay buffer
containing a final concentration of 3% methanol. In the calcium
assay, this translates to a maximum concentration of 1% methanol
exposure to the cells. To directly compare the potency of the H.
procumbens root extract with harpagoside, the dried root powder
was also solubilised in methanol and further diluted in assay buffer
to contain a 3% final methanol concentration. In a separate
experiment no significant differences in potency were observed
between the H. procumbens root powder solubilised in DMSO
versus methanol (data not shown). No toxicity was observed in the
resazurin assay for cells exposed either to up to 5% methanol or
H. procumbens root powder dissolved in assay buffer (data not
shown). Data was analysed using GraphPad Prism software
(PRISM 5.0; GraphPAD Software Inc., San Diego, CA, USA).
Sigmoidal dose-response curves were constructed using nonlinear
regression analysis with variable slope, excluding values resulting
from obvious incorrect pipetting by the Flexstation II.
Internalization assay
Hek-GHSR1a-EGFP cells were seeded in a poly-L-lysine
(Sigma-Aldrich) coated 96-well microtiter plate at 3*104 cells per
well and incubated for 48 h at culture conditions. For the last 24 h
of this time period media was replaced with serum free DMEM
media. Cells were treated with H. procumbens extract at 10 mg/
mL containing 1% DMSO, prepared as previously described in
the calcium mobilization assay, for 1 h at 37uC. The cells were
fixed with 4% paraformaldehyde in phosphate buffer saline (PBS)
for 20 min, washed once with PBS and stained with 5 mg/mL
bisbenzimide (Sigma-Aldrich) for 5 min. After bisbenzamide
staining, cells were washed three times with PBS and imaged on
the GE Healthcare IN Cell Analyser 1000 (GE Healthcare,
Buckinghamshire, UK) in PBS. Ghrelin was used as positive
control. In addition, treatment with the inverse agonist, [D-Arg1,
D-Phe5, D-Trp7,9, Leu11]-substance P, and the antagonist
D[Lys3]-GHSR6 (Tocris, R&D Systems) were also carried out.
The potential of compounds to internalize the receptor expressed
with a C-terminal enhanced green fluorescent protein (EGFP) tag
was analysed using ImageJ 1.46r software (National Institutes of
Health, MD, USA). In total 12 individual cells across 3
independent images were analysed and fluorescence intensity of
perinuclear receptor expression versus plasma membrane was
determined. The single highest intracellular pixel intensity was
compared to highest membrane pixel intensity along a straight line
axis in each selected cell. The average pixel intensity ratio of each
treatment was expressed as the mean 6 SEM. Data were analysed
and depicted using GraphPad Prism software (PRISM 5.0;
GraphPAD Software Inc.).
Cumulative food intake
Male C57BL/6 mice (purchased from Harlan laboratories,
Derby, UK) were single-housed in standard holding cages. On
date of arrival mice were 6–7 weeks of age. The holding room
temperature (2161uC) and humidity (55610%) were controlled
and under a 12 h light/dark cycle (lights on 7.00 AM, lights off
7.00 PM). Water and food (2018S Teklad Global 18% Protein
Rodent Diet, Harlan laboratories) were ad libitum available during
whole study unless indicated otherwise. The mice were habituated
on three independent days to the experimental settings. Cumu-
lative food intake studies, with ten animals per group, were
performed based on protocols described in previous studies
[33,34]. The sample size is based on a power calculation aimed
at detecting differences at the 0.05 level. Briefly, the body weight of
the mice was determined and the mice were single-housed in new
cages in the experimental room and habituated for 20 minutes
before injections. H. procumbens root extract (500 mg/kg and
200 mg/kg in saline containing 2.5% DMSO) and vehicle (saline
containing 2.5% DMSO) were administered via intraperitoneal
(IP) administration (10 ml/gram of body weight). A pre-weighed
chow food pellet was placed in the experimental cages 20 minutes
after IP injection. Thereafter, the amount of food consumed was
weighed in regular time intervals (20 min, 40 min, 1 h,
1 h30 min, 2 h, 3 h, 4 h, 5 h and 6 h). At the end of the
experiment the mice were placed back in their original cages in the
holding room. Data was analysed using GraphPad Prism software
(PRISM 5.0; GraphPAD Software Inc.).
Statistical analysis
Statistical analyses were performed using SPSS software (IBM
SPSS statistics 20). Statistical analysis for calcium mobilization
assay was performed using a Levene’s Test for the analysis of the
equality of the variances followed by an independent sample T-
test, for internalization assay a one-way ANOVA with LSD post
hoc test was used. Statistical analyses for in vivo studies were
performed using a general linear model repeated measurement.
Statistical significances are subsequently depicted as follows: *
indicating p,0.05, ** indicating p,0.01 or *** indicating p,
0.001.
Results
Chemical characterization of the dried Harpagophytum
procumbens root powder
To allow a better understanding of the possible bioactives found
in the dried H. procumbens root powder we analysed its chemical
composition (Table 1). The dried H. procumbens root powder
was poor in protein (1%), lipids (0.79%), polyphenols (1.16%) and
saccharides (2.53%). The most abundant components were fibre
(22.9%) and carbohydrates other than saccharides (62.4%). In
addition, previous studies have identified iridoid glycosides as the
main phytochemicals in H. procumbens (for review see [20]).
These compounds are cyclopentanoid monoterpene-derived com-
pounds with a glycoside bound as an O-linked glucoside and may,
therefore, be present in this major fraction. One of the major
iridoid glycosides described in H. procumbens is harpagoside [35]
and has been included in this study.
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Harpagophytum procumbens root extract potently
activates the GHS-R1a receptor in vitro
The potential cytotoxicity of H. procumbens root extract was
analysed to test its suitability for cell culture studies. This was
assessed by the resazurin assay, which is a widely used method to
analyse viability of bacteria and mammalian cells [36]. Viability of
Hek cells is depicted (Figure 1), calculated as percentage of
control (cells in HBSS). Cells were exposed for 4 h to H.
procumbens root extract at different concentrations, up to 10 mg/
mL (Figure 1A) and purified Harpagoside (Figure 1B). No
cytotoxic effects were observed (,90%), showing a cellular
viability around 100% with respect to the control, which makes
H. procumbens root extract a safe, suitable compound for the
cellular calcium mobilization assay.
GHS-R1a receptor modulation following H. procumbens root
extract exposure was analysed in the calcium mobilization assay in
Hek-GHS-R1a-EGFP cells and compared to the intracellular
calcium increase mediated by the endogenous ligand, ghrelin
(Figure 2). No calcium influx was observed in wild-type Hek cells
(Hek293A wt) not expressing the GHS-R1a receptor when
exposed to H. procumbens root extract (Figure 2A). In contrast,
exposure of Hek cells stably expressing the GHS-R1a receptor to
H. procumbens root extract did demonstrate a GHS-R1a receptor-
mediated calcium influx in a dose dependent manner (Fig-
ure 2B). Efficacy (Emax) and the half maximal effective
Figure 1. H. procumbens root extract has no cytotoxicity on Hek cells (Hek293a). Cellular viability was around 100% after exposure to
different concentrations of H. procumbens root extract up to 10 mg/mL (A) or purified Harpagoside up to 1 mg/mL (B). Results are expressed as
percentage of viability with respect to the control (cells in 1x HBSS containing 20 mM HEPES). Graph represents the mean6 SEM of triplicate samples
from one representative assay.
doi:10.1371/journal.pone.0103118.g001
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concentration (EC50) of H. procumbens mediated GHS-R1a
receptor activation was compared to that of ghrelin (Figure 2C).
Both ghrelin and the H. procumbens extract showed an efficacy .
80% compared to control, indicating that both behave as full
GHS-R1a receptor agonist, in the calcium mobilization assay.
However, the EC50 was shown to be approximately 1000-fold
lower (table 2) for the H. procumbens extract compared to
ghrelin, which may not be surprising since the H. procumbens
extract consists of a mixture of different compounds, resulting in
an overall dilution of bioactive potency in its ability to activate the
GHS-R1a receptor. Competing Interest statement, activation of
the GHS-R1a receptor by its endogenous agonist ghrelin was
shown to result in an increased intracellular calcium influx above
100% at concentrations exceeding 1 mg/mL (Figure 2C). This
may be due to the additive effect of several mechanisms of calcium
mobilization, including IP3 release of intracellular stores from the
endoplasmic reticulum, entry of calcium across the plasma
membrane via calcium permeable channels, and by mechanisms
that export or re-sequester calcium after receptor activation. This
warrants further investigations.
In a second experiment, the H. procumbens root extract-
mediated calcium mobilization following pre-treatment with the
GHS-R1a receptor specific inverse agonist peptide, [D-Arg1, D-
Phe5, D-Trp7,9, Leu11]-substance P (SP), was analysed (Fig-
ure 3A). SP-analogue was reported as a potent inverse agonist for
the GHS-R1a receptor attenuating its high ligand independent
basal activity [37]. Consequently, exposure to SP-analogue has
been shown to significantly increase membrane GHS-R1a
receptor expression and sensitize receptor signalling [38,39].
Calcium increase was not significant different following exposure
to H. procumbens root extract concentrations at the lowest
concentrations (0.25 and 0.125 mg/mL) of SP-analogue pre-
treatment. However, H. procumbens root extract exposure
following SP-analogue pre-treatment did significantly enhance
the GHS-R1a receptor mediated calcium influx at 3, 1 and
0.5 mg/mL. Statistical significance was determined at t(4) = 8.409;
p,0.001, t(4) = 5.314; p,0.01 and t(4) = 1.348; p,0.01, respec-
tively.
Next, we analysed harpagoside, the most studied compound in
H. procumbens, for its ability to activate the GHS-R1a receptor in
vitro. No increase in the intracellular calcium influx was observed
after its exposure at different concentrations (Figure 3B). These
results suggest that the H. procumbens root extract-mediated
calcium mobilization is not due to the presence of harpagoside in
the extract.
GHS-R1a receptor internalization is not affected by
Harpagophytum procumbens root extract
The GHS-R1a receptor has a high constitutive activity in the
absence of ligand. Following ligand-mediated receptor activation a
desensitization process occurs in order to protect the cell against
receptor overstimulation [40]. This process of desensitization is a
consequence of a combination of the uncoupling of the receptor
from heterotrimeric G proteins and its internalization from
membrane to intracellular compartments into endosomes [40].
Then, the receptor is marked for degradation or recycling back to
the membrane and is a hallmark of receptor activation [41].
Internalization of the GHS-R1a receptor was investigated in
Hek cells stably expressing the receptor as an EGFP-tagged fusion
construct. GHS-R1a receptor trafficking could be monitored
following analysis of EGFP fluorescent translocation from the
cellular membrane into endosomes within the cytosol (Figure 4).
Clear internalization of the GHS-R1a receptor could be observed
after treatment with the endogenous agonist ghrelin at 100 and
500 nM (Figure 4B, 4C). Ghrelin-mediated GHS-R1a receptor
internalization resulted in a high significant increased cytosol/
membrane EGFP fluorescent intensity ratio (p,0.001) with
respect to untreated cells (cells in assay buffer) (Figure 4G). In
contrast, treatment with 100nM of the inverse agonist SP-
analogue resulted in a higher GHS-R1a-EGFP expression in the
membrane with respect to untreated cells (Figure 4D) and
consequently showed a significant decreased cytosol/membrane
EGFP fluorescent intensity ratio (p,0.05) (Figure 4G). In
addition, the GHSR-R1a internalization after exposure to 5 mM
of the ghrelin-receptor antagonist (Dlys3)-GHRP-6 was also
analysed (Figure 4E). This antagonist has been widely used in
in vivo and in vitro studies to antagonize the GHS-R1a receptor
[34,42]. Indeed, the GHS-R1a receptor antagonist, (Dlys3)-
GHRP-6 significantly decreases the membrane/cytosol EGFP
fluorescent intensity ratio (p,0.05) compared to untreated cells,
which would correspond to higher levels of GHS-R1a receptor
membrane expression (Figure 4G). Interestingly, the H. procum-
bens root extract did not significantly change GHS-R1a-EGFP
fluorescence translocation, despite its high potency to induce a
GHS-R1a receptor-mediated calcium influx (Figure 4F, 4G).
Harpagophytum procumbens extract potently decreases
cumulative food intake
Finally, the effect of H. procumbens root extract on cumulative
food intake was investigated in male C57BL/6 mice (n = 10 per
cohort) during the light cycle (Figure 5). H. procumbens root
extract (200 and 500 mg/kg in saline containing 2.5% DMSO)
Table 1. Chemical composition of the dried H. procumbens root powder.
Components Dried H. procumbens root (g/100 g)
Protein 1.0260.01
Moisture 5.7660.06
Ash 3.4160.06
Lipids 0.7960.00
Fibre 22.9160.14
Polyphenols 1.1660.00
Soluble carbohydrates 2.5360.06
Insoluble carbohydrates* 62.42
*calculated by difference.
doi:10.1371/journal.pone.0103118.t001
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were administered to ad libitum fed mice via IP injection at 20
minutes before placement of food pellets in the cages (Figure 5A,
5B). Cumulative food intake was measured in regular intervals. An
overall significant effect of exposure to 200 mg/kg H. procumbens
root extract was observed F(1,18) = 1.761; p,0.201, as well as a
significant main effect of time F(2.688,48.377) = 147.786; p,
0.001, and an interaction of time and drug,
F(2.688,48.377) = 1.312; p,0.281. Exposure to H. procumbens
at 500 mg/kg showed a significant interaction of time and drug
F(2.202,39.640) = 4.634;p,0.013, as well as a significant main
effect of time F(2.202,39.640) = 137.707;p,0.001, and a signifi-
cant main effect of drug; F(1,18) = 5.680;p,0.028. The highest
dose administration of H. procumbens root extract (500 mg/kg)
significantly decreased cumulative food intake compared to vehicle
Figure 2. H. procumbens root extract induces GHS-R1a-mediated calcium influx. Calcium influx in Hek293a (wild type) cells versus Hek-GHS-
R1a-EGFP cells (A) and dose response curves of H. procumbens root extract (B) and ghrelin (C) are depicted. Exposure to ghrelin, the endogenous
ghrelin receptor ligand, and H. procumbens root extract potently increase intracellular calcium through activation of the GHS-R1a receptor in a dose
dependent manner. Calcium increase was depicted as a percentage of maximal calcium increase as elicited by control in each separate experiment
(3.33% FBS). The data represents the mean 6 SEM of a representative experiment out of three independent experiments with each concentration
point performed in triplicate.
doi:10.1371/journal.pone.0103118.g002
Table 2. Efficacy and EC50 of H. procumbens extract for GHS-R1a receptor-mediated calcium mobilization.
Ghrelin H. procumbens extract
Emax (%) 121.869.8 87.3614.7
EC50 (mg/mL) 0.215*102360.06 0.35160.11
Emax and EC50 values were obtained using GraphPad Prism software.
doi:10.1371/journal.pone.0103118.t002
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up to 4 h (Figure 5B), while exposure to the lower dose (200 mg/
kg) did not reach significance (Figure 5A). Nevertheless, the lower
dose of the extract did attenuate cumulative food intake which
almost reached statistical significance at 2 h (p,0.058). In
addition, cumulative food intake in individual time bins was also
studied to provide information on food patterning. Exposure to the
lower dose reached significance in the time bins from 20 min to
40 min, 40 min to 1 hr and 1.5 hr to 2 hr (Figure 5C) while
exposure to the highest dose of H. procumbens root extract
(500 mg/kg) significantly reduced food intake in time bins 20 min
to 40 min, 40 min to 1 h, 1 h to 1 h30 min and 1.5 h to 2 h
(Figure 5D). During the food intake study, no aberrant behaviour
was observed in the animals.
In addition, the anorexigenic effect of H. procumbens root
extract in food-restricted mice was investigated (Figure 6A, 6B).
A clear significant attenuation of cumulative food intake was
shown following H. procumbens extract treatment (Figure 6A)
with a significant interaction of time and drug;
F(2.869,51.649) = 6.472;p,0.001 as well as a significant main
effect of time; F(2.869,51.649) = 182.283;p,0.001 and a signifi-
Figure 3. H. procumbens root extract specifically activates GHS-R1a receptor independent of harpagoside. Calcium mobilization upon
exposure to H. procumbens root extract and harpagoside in Hek cells stably expressing the GHS-R1a receptor as an EGFP fusion protein. H.
procumbens root extract induced GHS-R1a receptor activation was enhancedfollowing attenuation of constitutive receptor activity by pre-treatment
with the GHS-R1a receptor inverse agonist, [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P (500 nM, SP-analogue) (A). The iridoid glycoside
harpagoside, one of the main compounds present in H. procumbens, did not show an enhanced GHS-R1a receptor-mediated calcium influx,
suggesting that the activity observed in this extract is due to others compounds present (B). Graph represents the mean 6 SEM of a representative
experiment from three (A) or two (B) independents experiments with each concentration point performed in triplicate. Intracellular calcium increase
was depicted as a percentage of maximal calcium increase as elicited by control (3.3% FBS). ***p,0.001, **p,0.01 compared with no [D-Arg1, D-
Phe5, D-Trp7,9, Leu11]-substance P pre-treatment.
doi:10.1371/journal.pone.0103118.g003
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cant main effect of drug; F(1,18) = 8.330;p,0.01. A significant
difference was observed between groups after 20 min, 40 min,
1 h, 1 h30 min, 2 h, 3 h and 4 h in cumulated food intake of p,
0.05, p,0.01, p,0.01, p,0.01, p,0.001, p,0.01 and p,0.01
respectively. Again when analysing individual time bins signifi-
cance was mainly observed in the time bins up to and including
2 h following food placement (Figure 6B), which normalized
thereafter.
Discussion
Traditionally, H. procumbens has been used as an herbal
medicine for a variety of conditions, and currently it is mainly used
as an anti-inflammatory agent and as an analgesic [21]. In
addition, it has been traditionally (but anecdotally) used as a
modulator of appetite [43]. However, scientific studies evaluating
the effect on food intake are lacking. In this paper we show, to our
knowledge for the first time, the ability of H. procumbens root
extract to modulate the GHS-R1a receptor, which is a key
receptor implicated in appetite stimulation following activation by
its agonist ghrelin. The H. procumbens extract was able to potently
stimulate an intracellular calcium influx in vitro. In addition, the
H. procumbens root extract-mediated GHS-R1a receptor modu-
lation was enhanced in response to GHS-R1a receptor sensitiza-
tion following pre-treatment with the inverse agonist peptide, [D-
Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P (SP). It was shown
that the H. procumbens root extract-mediated GHS-R1a receptor
response is not due to the presence of the main iridoid glycoside
harpagoside, contained within the plant, suggesting that other
compounds in the extract are responsible for the interaction with
the GHS-R1a receptor.
We also analysed the effect of H. procumbens extract on GHS-
R1a receptor internalization into endosomes, which is a charac-
teristic of full receptor activation and subsequently follows receptor
desensitization [41]. Both desensitization and internalization
processes provide essential physiological ‘‘feedback’’ mechanisms
that protect against both acute and chronic overstimulation of
receptors [44,45]. However, no internalization of the receptor was
observed following H. procumbens root extract exposure suggest-
ing that this extract does not act as a full GHS-R1a receptor
agonist. Inverse agonists, like SP have been shown to decrease
constitutive activity leading to enhanced ligand-mediated calcium
signalling [38,39], which is confirmed in this study as H.
procumbens-mediated calcium increase through the GHS-R1a
Figure 4. H. procumbens root extract does not internalize the GHS-R1a receptor. Hek cells stably expressing the GHS-R1a receptor as a C-
terminal EGFP fusion protein were visualized using the IN Cell Analyser 1000 (GE Healthcare) following different treatments: untreated (A), ghrelin
(B,C), [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P (SP-analogue) (D), (Dlys3)-GHRP-6 (E) and H. procumbens root extract (F) at the indicated
concentrations for 1 h at 37uC. Ligand-mediated GHS-R1a-EGFP translocation is quantified following the EGFP fluorescent trafficking away from
membrane into vesicles within the cytosol. Graph represents the mean6 SEM of the fluorescence intensity of perinuclear receptor expression versus
plasma membrane receptor expression from a representative experiment out of two independent experiments with each treatment performed in
triplicate (G). Significant increased internalization is depicted as *** p,0.001, and significant decreased internalization is depicted as ##p,0.01,
#p,0.05 with respect to internalization obtained from assay buffer (blanc).
doi:10.1371/journal.pone.0103118.g004
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receptor is increased following pre-treatment with SP. However,
H. procumbens root extract did not increase GHS-R1a receptor
expression on the membrane like SP did and it is thus unlikely to
act in a similar matter as an inverse agonist.
Receptors are phosphorylated by G-protein coupled receptor
kinases (GRK) following agonist-mediated activation and this
process activates proteins involved in G protein-coupled receptors
(GPCR) internalization [44,45], such as b-arrestin, which is the
most widely standard adaptor for GPCR endocytosis [46]. Indeed,
GHSR-1a receptor stimulation by the endogenous ligand ghrelin
induces b-arrestin recruitment and activates the mitogen-activated
protein kinase (MAPK) pathway (for review see [47,48]). Perhaps,
b-arrestin recruitment is not mediated by H. procumbens-
mediated GHS-R1a receptor activation, as b-arrestin independent
recruitment has also been demonstrated, which warrants further
investigations. Thus, we show that the H. procumbens-mediated
intracellular calcium signalling alone is not sufficient to promote
GHS-R1a receptor internalization and full receptor activation.
Interestingly, a significant dose-dependent decrease in food intake
was observed following intraperitoneal administration of H.
procumbens root extract in ad libitum fed mice as well as a
decrease in intake in food restricted mice. The major significant
appetite effect of H. procumbens occurs within the first 2 hours of
administration (Figure 5, 6). This early effect on appetite is in
line with the orexigenic effects of the endogenous GHS-R1a
receptor ligand, ghrelin, which are also only observed within the
first 2 hours of administration [34].
We hypothesize that the H. procumbens root extract interacts
with the GHS-R1a receptor, as elicited by increased intracellular
calcium influx, but does not lead to subsequent GHS-R1a receptor
internalization and, therefore, does not act as full GHS-R1a
receptor agonist. This may suggest that the GHS-R1a receptor
internalization is required for further down-stream orexigenic
effect in vivo. It is indeed tempting to speculate that the orexigenic
effects of the endogenous ligand ghrelin are dependent on GHS-
R1a receptor internalization, which occurs immediately following
calcium signalling. Moreover, we suggest that modulation of the
GHS-R1a receptor by the H. procumbens extract may decrease
the availability of the receptor to the orexigenic effects of ghrelin,
which may explain the observed anorexigenic effects.
Figure 5. Anorexigenic effect of H. procumbens root extract in ad libitum conditions. Cumulative food intake (A,B) and food intake per time
bin (C,D) in ad libitum fed C57BL/6 mice following intraperitoneal administration of H. procumbens root extract (200 and 500 mg/kg; 2.5% DMSO) and
vehicle (saline; 2.5% DMSO). Results are depicted in line graphs 6 SEM. Statistical significant differences compared to vehicle are depicted as * p,
0.05, ** p,0.01 or *** p,0.001, n = 10 per group.
doi:10.1371/journal.pone.0103118.g005
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Further investigations are needed to clarify the precise GHS-
R1a receptor-mediated intracellular signal transduction pathways
and correlate these to physiological behaviours. A recent study has
shown that GHS-R1a receptor knock-down, inverse agonism, or
desensitization can exert the same biological effect under certain
circumstances [49]. However, in relation to food intake, GHS-R1a
receptor inverse agonism has been reported to reduce appetite and
body weight gain [49] in contrast to the orexigenic effects of
ghrelin. Interestingly, biased agonism has also been reported for
GPCRs modulation leading to different active receptor confor-
mations adding to the complexity of GHS-R1a receptor signalling
(for review [48]). Hence, different intracellular signal transduction
pathways may be triggered by ghrelin, inverse agonists and H.
procumbens extract.
Furthermore, we cannot rule out that the H. procumbens root
extract interacts with other receptors implicated in satiety, such as
the serotonin receptors (5-HT1B, 5-HT2C and 5-HT6), cholecys-
tokinin receptor (CKK-A) and glucagon-like peptide-1 receptor
(GLP-1R), suppressing appetite. However, to our knowledge no
such interactions have been reported to date. Future studies using
GHS-R1a receptor antagonists or GHS-R1a knock-out mice may
be able to further delineate the molecular mechanism of the GHS-
R1a receptor-dependent anorexigenic effects of H. procumbens.
Finally, it would also be interesting to investigate if the H.
procumbens-mediated anorexigenic effect is maintained following
oral administration and if the bioactive has proteolytic stability in
transit.
Following compositional analysis, the most abundant com-
pounds in the dried H. procumbens root powder were demon-
strated as carbohydrates. Among these compounds, the most
potential active constituent of the extract are iridoids glycosides
(for review see [20]). In this study we show that harpagoside,
previously demonstrated as the main iroid glycoside in H.
procumbens [50], does not have any GHS-R1a activating
potential. Therefore, harpagoside is not implicated in the
interaction between H. procumbens extract and the GHS-R1a
receptor. However, others iridoids glycosides may be implicated.
In addition, the dried H. procumbens root was also rich in fibre.
Several studies have shown that consumption of diets rich in fibre
lead to beneficial anti-obesity effects such as increased satiety,
reduced hunger, reduced food intake, and body weight loss (for
review see [51]). Fibre exerts these anti-obesity effects by acting in
the gastrointestinal tract through different mechanisms such as
increasing gastric distension, delaying gastric emptying, digestion
and absorption of nutrients, increasing insulin and glycemic
responses, affecting gut hormones secretion such as GLP-1,
peptide YY and neurotensin, reducing the absorption of fat and
increasing the fecal energy excretion (for review see [51]).
Therefore, fibre may also be potentially implicated in the
decreased food intake observed in vivo by affecting gastrointestinal
digestion process. However, further analyses are needed to
investigate a possible interaction of fibre with the ghrelin receptor,
which may be also implicated in the anorexigenic effect of H.
procumbens. Future studies are needed to identify the specific
bioactive responsible for the appetite suppressant effects of H.
procumbens. Nevertheless, as demonstrated in this study, the crude
H. procumbens extract has potent anorexigenic effects, which
would be sufficient to be utilized as a natural anti-obesity
treatment in its un-purified form. This significantly contributes
to its potential commercial application.
We conclude that H. procumbens root extract is a novel source
for potent anti-obesity bioactives with GHS-R1a mediated
appetite suppressant effects. Therefore, H. procumbens root
extract may represent a possible natural alternative which may
be safer and more attractive compared to current pharmacological
drugs, which are often associated with several side effects. Hence,
the identification of the GHS-R1a receptor modulating bioactive
from H. procumbens is poised to have important therapeutic
potential in obesity and obesity related diseases.
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Figure 6. Anorexigenic effect of H. procumbens root extract in food restricted condition. Cumulative food intake (A) and food intake per
time bin (B) in 16 h food restricted C57BL/6 mice following intraperitoneal administration of H. procumbens extract (500 mg/kg; 2.5% DMSO) and
vehicle (saline; 2.5% DMSO). Results are depicted in line graphs 6 SEM. Statistical significant differences compared to vehicle are depicted as * p,
0.05, ** p,0.01 or *** p,0.001, n = 10 per group.
doi:10.1371/journal.pone.0103118.g006
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